2) proliferative retinopathy
增殖性视网膜病变
1.
Role of nimodipine and platelet-derived growth factor in proliferative retinopathy;
尼莫地平和血小板衍生生长因子在增殖性视网膜病变中的作用(英文)
2.
9%, the main causes were proliferative retinopathy, se.
9% ,致盲原因是增殖性视网膜病变、继发性青光眼和并发性白内障等。
3) proliferative diseases
增殖性疾病
1.
Trapping of growth factors of proliferative diseases by epigallocatechin gallate;
表没食子儿茶素没食子酸酯对增殖性疾病生长因子的诱捕作用
4) PDR
增殖性糖尿病性视网膜病变
1.
Objective:To explore the effect and the filling material of vitrectomy combining with laser on the treatment of PDR.
目的:观察分析玻璃体切割联合激光治疗增殖性糖尿病性视网膜病变的疗效及充填材料选择。
2.
Objective:To assess the incidence of apoptosis in epiretinal membranes from eyes with proliferative vitreoretinopathy(PVR),proliferative diabetic retinopathy (PDR),and macular pucker (MP) and to further investigate the potential involvement of key executors of apoptosis.
方法 :2 3例增殖性玻璃体视网膜病变 (PVR) ,增殖性糖尿病性视网膜病变 (PDR) ,黄斑裂孔 (MH)及黄斑前膜 (MP)的视网膜前膜 (epiretinalmem brane,ERM )由玻璃体切割术中取得。
5) non-proliferative diabetic retinopathy
非增殖性糖尿病视网膜病变
1.
Objective To evaluate the safety and efficacy of Calcium Dobesilate in subjects with non-proliferative diabetic retinopathy (NPDR).
目的评估羟苯磺酸钙治疗非增殖性糖尿病视网膜病变的有效性和安全性。
6) proliferative diabetic retinopathy
增殖性糖尿病视网膜病变
1.
Quantitative analysis of pigment epithelium derived factor in vitreous with proliferative diabetic retinopathy;
增殖性糖尿病视网膜病变玻璃体中PEDF的定量分析
2.
Clinical study of post-laser consolidating the efficacy of vitrectomy in treatment of proliferative diabetic retinopathy;
术后激光对巩固玻璃体切割治疗增殖性糖尿病视网膜病变手术效果的观察
3.
Effect of combined operation for proliferative diabetic retinopathy complicated with cataract;
联合手术治疗增殖性糖尿病视网膜病变合并白内障的效果评价
补充资料：膜性增殖性肾小球肾炎
膜性增殖性肾小球肾炎
membrano?proliferative glomerulonephritis
光镜下可见肾小球系膜细胞增生、系膜基质增加和扩展以及毛细血管壁增厚。电镜观察可分为3种亚型。Ⅰ型：增生的系膜细胞和基质伸入到基膜与内皮细胞之间，使毛细血管壁似乎分裂成双层而增厚，毛细血管腔被压而变窄；Ⅱ型：肾小球膜内出现电子致密沉积物，又称致密沉积物病；Ⅲ型：沉积物不规则地出现在毛细血管壁内。临床上本型多见于肾炎性肾病及慢性肾炎，血清C3持续明显降低，又称低补体血症性肾炎。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条